Unione Europea -
italiano -
EMA (European Medicines Agency)
talvey
janssen-cilag international n.v. - talquetamab - mieloma multiplo - agenti antineoplastici - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
talvey 3 mg/1.5 ml soluzione iniettabile
janssen-cilag ag - talquetamabum - soluzione iniettabile - talquetamabum 3 mg, natrii acetas ut natrii acetas trihydricus, acidum aceticum glaciale, saccharum, polysorbatum 20, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 1.5 ml corresp. natrium 0.38 mg. - multipli myelom - biotechnologika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
talvey 40 mg/1.0 ml soluzione iniettabile
janssen-cilag ag - talquetamabum - soluzione iniettabile - talquetamabum 40 mg, natrii acetas ut natrii acetas trihydricus, acidum aceticum glaciale, saccharum, polysorbatum 20, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 0.25 mg. - multipli myelom - biotechnologika
Unione Europea -
italiano -
EMA (European Medicines Agency)
minjuvi
incyte biosciences distribution b.v. - tafasitamab - lymphoma, large b-cell, diffuse - agenti antineoplastici - minjuvi is indicated in combination with lenalidomide followed by minjuvi monotherapy for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) who are not eligible for autologous stem cell transplant (asct).
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
minjuvi 200 mg polvere per soluzione per infusione
incyte biosciences international sàrl - tafasitamabum - polvere per soluzione per infusione - praeparatio cryodesiccata: tafasitamabum 200 mg, natrii citras dihydricus corresp. natrium 7.4 mg, acidum citricum monohydricum, trehalosum dihydricum, polysorbatum 20, pro vitro. - lymphome diffus à grandes cellules b (dlbcl) - biotechnologika